Global Biosimilars Treatment Market Size, Status and Forecast 2025

February 2018 | 106 pages | ID: G6A9EE1556EEN
QYResearch

Abstracts

This report studies the global Biosimilars Treatment market, analyzes and researches the Biosimilars Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Bayer
• Eli Lily, Inc.
• Pfizer, Inc.
• Sandoz International GmbH
• Teva Pharmaceutical Industries Limited
• Amgen Inc.
• Biocon
• Dr. Reddy’s Laboratories
• Roche Ltd.
• Celltrion, Inc.
• Samsung Bioepis

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Recombinant Non – Glycosylated Proteins
• Recombinant Glycosylated Proteins
• Recombinant Peptides

Market segment by Application, Biosimilars Treatment can be split into

• Oncology
• Chronic and Autoimmune Disease
• Blood Disorders
• Growth Hormone Disease
• Infectious Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Biosimilars Treatment Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF BIOSIMILARS TREATMENT

1.1 Biosimilars Treatment Market Overview
  1.1.1 Biosimilars Treatment Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Biosimilars Treatment Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Biosimilars Treatment Market by Type
  1.3.1 Recombinant Non – Glycosylated Proteins
  1.3.2 Recombinant Glycosylated Proteins
  1.3.3 Recombinant Peptides
1.4 Biosimilars Treatment Market by End Users/Application
  1.4.1 Oncology
  1.4.2 Chronic and Autoimmune Disease
  1.4.3 Blood Disorders
  1.4.4 Growth Hormone Disease
  1.4.5 Infectious Disease

2 GLOBAL BIOSIMILARS TREATMENT COMPETITION ANALYSIS BY PLAYERS

2.1 Biosimilars Treatment Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Bayer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Eli Lily, Inc.
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Pfizer, Inc.
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Sandoz International GmbH
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Teva Pharmaceutical Industries Limited
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Amgen Inc.
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Biocon
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Dr. Reddy’s Laboratories
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 Roche Ltd.
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Celltrion, Inc.
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Biosimilars Treatment Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Samsung Bioepis

4 GLOBAL BIOSIMILARS TREATMENT MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Biosimilars Treatment Market Size by Type (2013-2018)
4.2 Global Biosimilars Treatment Market Size by Application (2013-2018)
4.3 Potential Application of Biosimilars Treatment in Future
4.4 Top Consumer/End Users of Biosimilars Treatment

5 UNITED STATES BIOSIMILARS TREATMENT DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Biosimilars Treatment Market Size (2013-2018)
5.2 United States Biosimilars Treatment Market Size and Market Share by Players (2013-2018)
5.3 United States Biosimilars Treatment Market Size by Application (2013-2018)

6 EU BIOSIMILARS TREATMENT DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Biosimilars Treatment Market Size (2013-2018)
6.2 EU Biosimilars Treatment Market Size and Market Share by Players (2013-2018)
6.3 EU Biosimilars Treatment Market Size by Application (2013-2018)

7 JAPAN BIOSIMILARS TREATMENT DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Biosimilars Treatment Market Size (2013-2018)
7.2 Japan Biosimilars Treatment Market Size and Market Share by Players (2013-2018)
7.3 Japan Biosimilars Treatment Market Size by Application (2013-2018)

8 CHINA BIOSIMILARS TREATMENT DEVELOPMENT STATUS AND OUTLOOK

8.1 China Biosimilars Treatment Market Size (2013-2018)
8.2 China Biosimilars Treatment Market Size and Market Share by Players (2013-2018)
8.3 China Biosimilars Treatment Market Size by Application (2013-2018)

9 INDIA BIOSIMILARS TREATMENT DEVELOPMENT STATUS AND OUTLOOK

9.1 India Biosimilars Treatment Market Size (2013-2018)
9.2 India Biosimilars Treatment Market Size and Market Share by Players (2013-2018)
9.3 India Biosimilars Treatment Market Size by Application (2013-2018)

10 SOUTHEAST ASIA BIOSIMILARS TREATMENT DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Biosimilars Treatment Market Size (2013-2018)
10.2 Southeast Asia Biosimilars Treatment Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Biosimilars Treatment Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Biosimilars Treatment Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Biosimilars Treatment Revenue and Growth Rate (2018-2025)
  11.1.2 EU Biosimilars Treatment Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Biosimilars Treatment Revenue and Growth Rate (2018-2025)
  11.1.4 China Biosimilars Treatment Revenue and Growth Rate (2018-2025)
  11.1.5 India Biosimilars Treatment Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Biosimilars Treatment Revenue and Growth Rate (2018-2025)
11.2 Global Biosimilars Treatment Market Size (Value) by Type (2018-2025)
11.3 Global Biosimilars Treatment Market Size by Application (2018-2025)

12 BIOSIMILARS TREATMENT MARKET DYNAMICS

12.1 Biosimilars Treatment Market Opportunities
12.2 Biosimilars Treatment Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Biosimilars Treatment Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Biosimilars Treatment Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Biosimilars Treatment Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Biosimilars Treatment Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Biosimilars Treatment Market Share by Regions (2013-2018)
Figure United States Biosimilars Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Biosimilars Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Biosimilars Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Biosimilars Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Biosimilars Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Biosimilars Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Biosimilars Treatment Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Biosimilars Treatment Revenue Market Share by Type in 2017
Figure Recombinant Non – Glycosylated Proteins Market Size (Million USD) and Growth Rate (2013-2018)
Figure Recombinant Glycosylated Proteins Market Size (Million USD) and Growth Rate (2013-2018)
Figure Recombinant Peptides Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Biosimilars Treatment Market Share by Application in 2017
Figure Biosimilars Treatment Market Size (Million USD) and Growth Rate in Oncology (2013-2018)
Figure Biosimilars Treatment Market Size (Million USD) and Growth Rate in Chronic and Autoimmune Disease (2013-2018)
Figure Biosimilars Treatment Market Size (Million USD) and Growth Rate in Blood Disorders (2013-2018)
Figure Biosimilars Treatment Market Size (Million USD) and Growth Rate in Growth Hormone Disease (2013-2018)
Figure Biosimilars Treatment Market Size (Million USD) and Growth Rate in Infectious Disease (2013-2018)
Table Biosimilars Treatment Market Size (Million USD) by Players (2013-2018)
Figure Biosimilars Treatment Market Size Share by Players in 2013
Figure Biosimilars Treatment Market Size Share by Players in 2017
Table Bayer Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Bayer (2013-2018)
Figure Bayer Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Eli Lily, Inc. Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Eli Lily, Inc. (2013-2018)
Figure Eli Lily, Inc. Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Pfizer, Inc. Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Pfizer, Inc. (2013-2018)
Figure Pfizer, Inc. Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Sandoz International GmbH Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Sandoz International GmbH (2013-2018)
Figure Sandoz International GmbH Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Teva Pharmaceutical Industries Limited Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Teva Pharmaceutical Industries Limited (2013-2018)
Figure Teva Pharmaceutical Industries Limited Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Amgen Inc. Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Amgen Inc. (2013-2018)
Figure Amgen Inc. Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Biocon Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Biocon (2013-2018)
Figure Biocon Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Dr. Reddy’s Laboratories Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Dr. Reddy’s Laboratories (2013-2018)
Figure Dr. Reddy’s Laboratories Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Roche Ltd. Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Roche Ltd. (2013-2018)
Figure Roche Ltd. Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Celltrion, Inc. Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Celltrion, Inc. (2013-2018)
Figure Celltrion, Inc. Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Samsung Bioepis Basic Information List
Table Biosimilars Treatment Business Revenue (Million USD) of Samsung Bioepis (2013-2018)
Figure Samsung Bioepis Biosimilars Treatment Business Revenue Market Share (2013-2018)
Table Global Biosimilars Treatment Market Size (Million USD) by Product (2013-2018)
Figure Global Biosimilars Treatment Revenue Market Share (%) by Product (2013-2018)
Figure Global Biosimilars Treatment Market Share by Product in 2017
Table Global Biosimilars Treatment Market Size by Application (2013-2018)
Figure Global Biosimilars Treatment Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Biosimilars Treatment
Figure United States Biosimilars Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Biosimilars Treatment Market Size (Million USD) by Players (2013-2018)
Figure United States Biosimilars Treatment Market Size Share by Players in 2013
Figure United States Biosimilars Treatment Market Size Share by Players in 2017
Table United States Biosimilars Treatment Market Size by Application (2013-2018)
Figure United States Biosimilars Treatment Revenue Market Share (%) by Application (2013-2018)
Figure United States Biosimilars Treatment Market Size Share by Application in 2017
Figure EU Biosimilars Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Biosimilars Treatment Market Size (Million USD) by Players (2013-2018)
Figure EU Biosimilars Treatment Market Size Share by Players in 2013
Figure EU Biosimilars Treatment Market Size Share by Players in 2017
Table EU Biosimilars Treatment Market Size by Application (2013-2018)
Figure EU Biosimilars Treatment Revenue Market Share (%) by Application (2013-2018)
Figure EU Biosimilars Treatment Market Size Share by Application in 2017
Figure Japan Biosimilars Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Biosimilars Treatment Market Size (Million USD) by Players (2013-2018)
Figure Japan Biosimilars Treatment Market Size Share by Players in 2013
Figure Japan Biosimilars Treatment Market Size Share by Players in 2017
Table Japan Biosimilars Treatment Market Size by Application (2013-2018)
Figure Japan Biosimilars Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Japan Biosimilars Treatment Market Size Share by Application in 2017
Figure China Biosimilars Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table China Biosimilars Treatment Market Size (Million USD) by Players (2013-2018)
Figure China Biosimilars Treatment Market Size Share by Players in 2013
Figure China Biosimilars Treatment Market Size Share by Players in 2017
Table China Biosimilars Treatment Market Size by Application (2013-2018)
Figure China Biosimilars Treatment Revenue Market Share (%) by Application (2013-2018)
Figure China Biosimilars Treatment Market Size Share by Application in 2017
Figure India Biosimilars Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table India Biosimilars Treatment Market Size (Million USD) by Players (2013-2018)
Figure India Biosimilars Treatment Market Size Share by Players in 2013
Figure India Biosimilars Treatment Market Size Share by Players in 2017
Table India Biosimilars Treatment Market Size by Application (2013-2018)
Figure India Biosimilars Treatment Revenue Market Share (%) by Application (2013-2018)
Figure India Biosimilars Treatment Market Size Share by Application in 2017
Figure Southeast Asia Biosimilars Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Biosimilars Treatment Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Biosimilars Treatment Market Size Share by Players in 2013
Figure Southeast Asia Biosimilars Treatment Market Size Share by Players in 2017
Table Southeast Asia Biosimilars Treatment Market Size by Application (2013-2018)
Figure Southeast Asia Biosimilars Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Biosimilars Treatment Market Size Share by Application in 2017
Figure Global Biosimilars Treatment Market Size and Growth Rate (2018-2025)
Table Global Biosimilars Treatment Market Size (Million USD) by Regions (2018-2025)
Figure Global Biosimilars Treatment Market Size Share (2018-2025)
Figure Global Biosimilars Treatment Market Size Share by Regions in 2025
Figure United States Biosimilars Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Biosimilars Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Biosimilars Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Biosimilars Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Biosimilars Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Biosimilars Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Biosimilars Treatment Market Size (Million USD) by Type (2018-2025)
Figure Global Biosimilars Treatment Market Size Share by Type in 2018
Figure Global Biosimilars Treatment Market Size Share by Type in 2025
Table Global Biosimilars Treatment Market Size (Million USD) by Application (2018-2025)
Figure Global Biosimilars Treatment Market Size (Million USD) by Application in 2018
Figure Global Biosimilars Treatment Market Size (Million USD) by Application in 2025